نتایج جستجو برای: cccdna

تعداد نتایج: 249  

Journal: :Molecular medicine reports 2014
Peng Ruan Boping Zhou Xiufang Dai Zequn Sun Xiaoyan Guo Jian Huang Zuojiong Gong

This study aimed to investigate the persistence and predictive values of intrahepatic (IH) hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and total DNA (tDNA) in patients with acute hepatitis B (AHB) and patients with chronic hepatitis B (CHB) receiving anti‑viral treatment. The levels of IH cccDNA and tDNA, serum HBV DNA, hepatitis B surface antigen (HBsAg), hepatitis B e anti...

Journal: :Viruses 2021

Approximately 240 million people are chronically infected with hepatitis B virus (HBV), despite four decades of effective HBV vaccination. During chronic infection, forms two distinct templates responsible for viral transcription: (1) episomal covalently closed circular (ccc)DNA and (2) host genome-integrated templates. Multiple ubiquitous liver-specific transcription factors recruited onto the...

2015
Geoffrey Dusheiko

Despite the introduction of vaccination, chronic hepatitis B remains a major cause of liver-related morbidity and mortality including cirrhosis, decompensated cirrhosis and hepatocellular carcinoma. Maintenance antiviral therapy is required for most people, as low rates of cure occur. The stated aim of therapy presently is HBV DNA suppression; effective suppression of viral replication is assoc...

Journal: :Science 2014
Julie Lucifora Yuchen Xia Florian Reisinger Ke Zhang Daniela Stadler Xiaoming Cheng Martin F Sprinzl Herwig Koppensteiner Zuzanna Makowska Tassilo Volz Caroline Remouchamps Wen-Min Chou Wolfgang E Thasler Norbert Hüser David Durantel T Jake Liang Carsten Münk Markus H Heim Jeffrey L Browning Emmanuel Dejardin Maura Dandri Michael Schindler Mathias Heikenwalder Ulrike Protzer

Current antiviral agents can control but not eliminate hepatitis B virus (HBV), because HBV establishes a stable nuclear covalently closed circular DNA (cccDNA). Interferon-α treatment can clear HBV but is limited by systemic side effects. We describe how interferon-α can induce specific degradation of the nuclear viral DNA without hepatotoxicity and propose lymphotoxin-β receptor activation as...

2015
Vyas Ramanan Amir Shlomai David B.T. Cox Robert E. Schwartz Eleftherios Michailidis Ankit Bhatta David A. Scott Feng Zhang Charles M. Rice Sangeeta N. Bhatia

Chronic hepatitis B virus (HBV) infection is prevalent, deadly, and seldom cured due to the persistence of viral episomal DNA (cccDNA) in infected cells. Newly developed genome engineering tools may offer the ability to directly cleave viral DNA, thereby promoting viral clearance. Here, we show that the CRISPR/Cas9 system can specifically target and cleave conserved regions in the HBV genome, r...

Journal: :Antiviral research 2000
W R Addison W W Wong K P Fischer D L Tyrrell

A crucial step in the establishment and maintenance of a hepadnavirus infection is the formation of a pool of covalently closed circular viral genomes in the nucleus. Changes in the size of this pool occur when an infection is established, when acute infections are resolved, and when chronic infections are treated with antiviral drugs. However, the lack of a quantitative assay for the cccDNA fo...

Journal: :Hepatitis Monthly 2022

Background: Several studies have revealed that the hepatitis B virus (HBV) exists in peripheral blood mononuclear cells (PBMCs). It remains poorly understood whether HBV DNA and covalently closed circular (cccDNA) can emerge PBMCs of patients with different stages infection. Objectives: This study aimed to compare detection quantification presence cccDNA within PBMC from chronic (CHB), cirrhosi...

2013
Kristie Bloom Abdullah Ely Claudio Mussolino Toni Cathomen Patrick Arbuthnot

Chronic hepatitis B virus (HBV) infection remains an important global health problem. Stability of the episomal covalently closed circular HBV DNA (cccDNA) is largely responsible for the modest curative efficacy of available therapy. Since licensed anti-HBV drugs have a post-transcriptional mechanism of action, disabling cccDNA is potentially of therapeutic benefit. To develop this approach, we...

2012
Sebastian Malmström Simon B. Larsson Charles Hannoun Magnus Lindh

BACKGROUND Quantification of hepatitis B virus (HBV) DNA and surface antigen (HBsAg) serum levels have become increasingly important for the assessment of clinical stage and response to treatment for chronic hepatitis B. Effective immune clearance results in reduction of viremia by 4-5 log units and HBsAg levels by 2 log, but these processes are not well understood. Thus, it is uncertain to wha...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید